X4 Pharmaceuticals

XFOR

Börsenwert 325 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	17,4 Mio. $	–	–	–
2	2 NEA Management Company Timonium, Maryland	16,3 Mio. $	–	–	–
3	3 BlackRock New York	8,89 Mio. $	-1,36 Mio. $	-31.281	-10 %
4	4 Vanguard Group Malvern, Pennsylvania	8,53 Mio. $	+54.649 $	+1.253	+0,5 %
5	5 Polar Capital Holdings London, United Kingdom	8,18 Mio. $	+10,9 Mio. $	+250.000	Neu
6	6 OrbiMed New York	7,78 Mio. $	–	–	–
7	TLP 7 Tri Locum Partners New York	6,81 Mio. $	+3,12 Mio. $	+71.585	+52 %
8	8 Stonepine Capital Management Bend, Oregon	5,75 Mio. $	+971.770 $	+22.281	+15 %
9	9 Adage Capital Partners Boston, Massachusetts	4,66 Mio. $	–	–	–
10	10 Millennium Management New York	3,94 Mio. $	-2,67 Mio. $	-61.188	-34 %
11	11 Perceptive Advisors New York	3,86 Mio. $	–	–	–
12	12 Axa Paris, France	3,43 Mio. $	-402.865 $	-9.237	-8 %
13	13 Geode Capital Management Boston, Massachusetts	2,88 Mio. $	+425.545 $	+9.757	+12 %
14	14 Sio Capital Management New York	2,83 Mio. $	+1,24 Mio. $	+28.333	+49 %
15	15 State Street Boston, Massachusetts	2,59 Mio. $	+231.243 $	+5.302	+7 %
16	16 Armistice Capital New York	2,57 Mio. $	-901.377 $	-20.667	-21 %
17	KCM 17 Kingdon Capital Management New York	2,15 Mio. $	–	–	–
18	18 Citadel Advisors Miami, Florida	1,96 Mio. $	-1,85 Mio. $	-42.503	-41 %
19	19 UBS O'Connor Chicago, Illinois	1,7 Mio. $	+1,61 Mio. $	+37.000	+247 %
20	20 Northern Trust Chicago, Illinois	1,16 Mio. $	+22.985 $	+527	+2 %
21	21 Parkman Healthcare Partners Stamford, Connecticut	872.000 $	-4,31 Mio. $	-98.886	-79 %
22	22 Point72 Asset Management Stamford, Connecticut	708.500 $	–	–	–
23	23 GSA Capital Partners London, United Kingdom	678.000 $	+903.688 $	+20.720	Neu
24	24 Schonfeld Strategic Advisors New York	638.785 $	-578.108 $	-13.255	-40 %
25	25 Bank of New York Mellon New York	517.416 $	-5.146 $	-118	-0,7 %

X4 Pharmaceuticals XFOR Börsenwert 325 Mio. $

X4 Pharmaceuticals

XFOR

Börsenwert 325 Mio. $